Left Atrial Appendage Closure With SentreHeart Lariat® Device
Part of paid clinical trials in Plano, Texas.
- Sponsor
- Baylor Research Institute
- Study ID
- NCT02681042
- Status
- Completed
Conditions
- Atrial Fibrillation
- Cardioembolic Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Left atrial appendage closure — PROCEDUREThe SentreHeart Lariat® device (that is approved for soft tissue ligation) will be used to ligate or close the left atrial appendage as a stand-alone procedure at the participating centers.
- SentreHeart Lariat® — DEVICEThe SentreHeart Lariat® device (that is approved for soft tissue ligation) will be used to ligate or close the left atrial appendage as a stand-alone procedure at the participating centers.
Study Details
The study cohort will consist of up to 50 patients who are candidates for Left Atrial Appendage (LAA) closure in whom oral anticoagulation is contraindicated. Subjects evaluated for left atrial appendage closure will be screened for inclusion and consented prior to their procedure. If the anatomy is favorable for placement of the Lariat® device, the procedure will be performed at one of the participating centers. If anatomy is not favorable, the patient will be excluded from the study and managed using best care practices by his or her physician.
Key Dates
- Start date
- Mar 31, 2015
- Status verified
- Jan 2026
- Primary completion
- May 2, 2018
- Completion
- May 2, 2018
Study Design
- Enrollment
- 9 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: SentreHeart LariatLeft atrial appendage closure with SentreHeart Lariat device
Primary Outcome Measure
Number of Participants With Successful Stand-Alone Left Atrial Appendage Closure Using SentreHeart Lariat Device as Measured by Left Atrial Appendage Closure Rates [ Time Frame: 180 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baylor Research Institute at The Heart Hospital Baylor Plano | Plano | Texas | 75093 | - |
Find similar trials in Plano, TX
Related Studies
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With StressPHASE4 · Recruiting · Population Health Research Institute · Los Angeles, California
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas